Amarna Therapeutics
Netherlands - LeidenBiotechnology
Focus: Amarna Therapeutics is a Netherlands-based biotech company specializing in viral gene delivery platforms for gene therapy applications. With 1-50 employees and founded in 2008, it operates as a pre-revenue private biotech at an early stage.
Profile data last refreshed 23h ago · AI intelligence enriched 2w ago
Funding Stage
PRIVATE
Employees
1-50
Open Jobs
0
About Amarna Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Amarna Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Bone Marrow Collection in Healthy Volunteers (iCell)
Spinal Cord InjuryClinical Trials (1)
NCT02118740Bone Marrow Collection in Healthy Volunteers (iCell)
N/AHelp build intelligence for Amarna Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.